Eyckmans L, Beert J
Infection. 1977;5(1):9-12. doi: 10.1007/BF01639102.
An in vitro study of the susceptibility of 201 newly isolated strains of gramnegative bacteria to six aminoglycoside antibiotics (kanamycin, amikacin, gentamicin, tobramycin, sisomicin and netilmicin) was performed by the twofold dilution method in fluid medium. Both the minimal inhibitory concentration and the minimal bacteridical concentration were determined. Overall, tobramycin seemed the most effective of the drugs studied. Netilmicin, the new derivative from sisomicin, compared favourably with the other drugs tested, but may, on theoretical grounds, offer the additional advantage of retained efficacy in the face of developing bacterial resistance. Not unexpectedly, amikacin appeared to be the most promising of the drugs studied in its action against Pseudomonas aeruginosa. Amikacin and netilmicin appeared to be the most effective of this group of antibiotics against Klebsiella species.
采用液体培养基中的两倍稀释法,对201株新分离的革兰氏阴性菌进行了体外药敏试验,检测其对六种氨基糖苷类抗生素(卡那霉素、阿米卡星、庆大霉素、妥布霉素、西索米星和奈替米星)的敏感性。同时测定了最低抑菌浓度和最低杀菌浓度。总体而言,在所研究的药物中,妥布霉素似乎最有效。奈替米星是西索米星的新衍生物,与其他受试药物相比效果良好,但从理论上讲,面对细菌耐药性的发展,它可能具有疗效维持的额外优势。不出所料,阿米卡星在对抗铜绿假单胞菌的作用方面似乎是所研究药物中最有前景的。阿米卡星和奈替米星似乎是这组抗生素中对抗克雷伯菌属最有效的。